Involvement of MAGP1 in β-TCP enhanced bone regeneration

Hung Ta Lin, Ujjal K. Bhawal, Takao Watanabe, Wei Jen Chang, Sheng Yang Lee, Yoshimitsu Abiko

Research output: Contribution to journalArticle

Abstract

Microfibril-associated glycoprotein-1 (MAGP1) is a small molecular weight, ubiquitous component of the fibrillin-rich microfibrils that found in the extracellular matrix. Inactivation of MAGP1 results in a bleeding diathesis and an altered wound healing response in bone and skin. Beta-tricalcium phosphate (β-TCP) is widely used in clinical orthopedic surgery due to its high biodegradability, osteoconductivity, easy manipulation and lack of histotoxicity. In this study, we aimed to understand the differential expression of MAGP1 in bone tissue implanted with β-TCP. Following the extraction of premolars and subsequent bone healing,β-TCP was implanted into the artificial osseous defect of dog mandibles. Bone tissue specimens were collected at 4 and 7 days after implantation. Total RNA was isolated from bone tissue, and gene expression profiles were analyzed using microarray technology. MAGP1 mRNA was up-regulated at days 4 and 7 in β-TCP-implanted tissues compared to the controls. Real-time PCR was used to confirm the mRNA levels. Immunohistochemical analysis revealed a higher expression in MAGP1 protein at day 7 in b-TCP-implanted tissues compared to the control. These results suggest that MAGP1 might be involved in the early stage of β-TCP enhanced bone regeneration.

Original languageEnglish
Pages (from-to)267-272
Number of pages6
JournalJournal of Hard Tissue Biology
Volume21
Issue number3
DOIs
Publication statusPublished - 2012

Fingerprint

Glycoproteins
Bone Regeneration
Bone
Tissue
Bone and Bones
Microfibrils
Messenger RNA
Biodegradability
Disease Susceptibility
Bicuspid
Orthopedics
Microarrays
RNA
Mandible
Transcriptome
Gene expression
Wound Healing
Surgery
Extracellular Matrix
microfibrillar protein

Keywords

  • β-TCP
  • Dog mandible
  • Gene expression
  • MAGP1
  • Microarray

ASJC Scopus subject areas

  • Biochemistry
  • Cell Biology
  • Biomaterials
  • Medicine (miscellaneous)
  • Orthopedics and Sports Medicine
  • Dentistry(all)

Cite this

Involvement of MAGP1 in β-TCP enhanced bone regeneration. / Lin, Hung Ta; Bhawal, Ujjal K.; Watanabe, Takao; Chang, Wei Jen; Lee, Sheng Yang; Abiko, Yoshimitsu.

In: Journal of Hard Tissue Biology, Vol. 21, No. 3, 2012, p. 267-272.

Research output: Contribution to journalArticle

Lin, Hung Ta ; Bhawal, Ujjal K. ; Watanabe, Takao ; Chang, Wei Jen ; Lee, Sheng Yang ; Abiko, Yoshimitsu. / Involvement of MAGP1 in β-TCP enhanced bone regeneration. In: Journal of Hard Tissue Biology. 2012 ; Vol. 21, No. 3. pp. 267-272.
@article{02e65d055feb4fde9bec779853acfe38,
title = "Involvement of MAGP1 in β-TCP enhanced bone regeneration",
abstract = "Microfibril-associated glycoprotein-1 (MAGP1) is a small molecular weight, ubiquitous component of the fibrillin-rich microfibrils that found in the extracellular matrix. Inactivation of MAGP1 results in a bleeding diathesis and an altered wound healing response in bone and skin. Beta-tricalcium phosphate (β-TCP) is widely used in clinical orthopedic surgery due to its high biodegradability, osteoconductivity, easy manipulation and lack of histotoxicity. In this study, we aimed to understand the differential expression of MAGP1 in bone tissue implanted with β-TCP. Following the extraction of premolars and subsequent bone healing,β-TCP was implanted into the artificial osseous defect of dog mandibles. Bone tissue specimens were collected at 4 and 7 days after implantation. Total RNA was isolated from bone tissue, and gene expression profiles were analyzed using microarray technology. MAGP1 mRNA was up-regulated at days 4 and 7 in β-TCP-implanted tissues compared to the controls. Real-time PCR was used to confirm the mRNA levels. Immunohistochemical analysis revealed a higher expression in MAGP1 protein at day 7 in b-TCP-implanted tissues compared to the control. These results suggest that MAGP1 might be involved in the early stage of β-TCP enhanced bone regeneration.",
keywords = "β-TCP, Dog mandible, Gene expression, MAGP1, Microarray",
author = "Lin, {Hung Ta} and Bhawal, {Ujjal K.} and Takao Watanabe and Chang, {Wei Jen} and Lee, {Sheng Yang} and Yoshimitsu Abiko",
year = "2012",
doi = "10.2485/jhtb.21.267",
language = "English",
volume = "21",
pages = "267--272",
journal = "Journal of Hard Tissue Biology",
issn = "1341-7649",
publisher = "Society of Hard Tissue Regenerative Biology",
number = "3",

}

TY - JOUR

T1 - Involvement of MAGP1 in β-TCP enhanced bone regeneration

AU - Lin, Hung Ta

AU - Bhawal, Ujjal K.

AU - Watanabe, Takao

AU - Chang, Wei Jen

AU - Lee, Sheng Yang

AU - Abiko, Yoshimitsu

PY - 2012

Y1 - 2012

N2 - Microfibril-associated glycoprotein-1 (MAGP1) is a small molecular weight, ubiquitous component of the fibrillin-rich microfibrils that found in the extracellular matrix. Inactivation of MAGP1 results in a bleeding diathesis and an altered wound healing response in bone and skin. Beta-tricalcium phosphate (β-TCP) is widely used in clinical orthopedic surgery due to its high biodegradability, osteoconductivity, easy manipulation and lack of histotoxicity. In this study, we aimed to understand the differential expression of MAGP1 in bone tissue implanted with β-TCP. Following the extraction of premolars and subsequent bone healing,β-TCP was implanted into the artificial osseous defect of dog mandibles. Bone tissue specimens were collected at 4 and 7 days after implantation. Total RNA was isolated from bone tissue, and gene expression profiles were analyzed using microarray technology. MAGP1 mRNA was up-regulated at days 4 and 7 in β-TCP-implanted tissues compared to the controls. Real-time PCR was used to confirm the mRNA levels. Immunohistochemical analysis revealed a higher expression in MAGP1 protein at day 7 in b-TCP-implanted tissues compared to the control. These results suggest that MAGP1 might be involved in the early stage of β-TCP enhanced bone regeneration.

AB - Microfibril-associated glycoprotein-1 (MAGP1) is a small molecular weight, ubiquitous component of the fibrillin-rich microfibrils that found in the extracellular matrix. Inactivation of MAGP1 results in a bleeding diathesis and an altered wound healing response in bone and skin. Beta-tricalcium phosphate (β-TCP) is widely used in clinical orthopedic surgery due to its high biodegradability, osteoconductivity, easy manipulation and lack of histotoxicity. In this study, we aimed to understand the differential expression of MAGP1 in bone tissue implanted with β-TCP. Following the extraction of premolars and subsequent bone healing,β-TCP was implanted into the artificial osseous defect of dog mandibles. Bone tissue specimens were collected at 4 and 7 days after implantation. Total RNA was isolated from bone tissue, and gene expression profiles were analyzed using microarray technology. MAGP1 mRNA was up-regulated at days 4 and 7 in β-TCP-implanted tissues compared to the controls. Real-time PCR was used to confirm the mRNA levels. Immunohistochemical analysis revealed a higher expression in MAGP1 protein at day 7 in b-TCP-implanted tissues compared to the control. These results suggest that MAGP1 might be involved in the early stage of β-TCP enhanced bone regeneration.

KW - β-TCP

KW - Dog mandible

KW - Gene expression

KW - MAGP1

KW - Microarray

UR - http://www.scopus.com/inward/record.url?scp=84865833854&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865833854&partnerID=8YFLogxK

U2 - 10.2485/jhtb.21.267

DO - 10.2485/jhtb.21.267

M3 - Article

AN - SCOPUS:84865833854

VL - 21

SP - 267

EP - 272

JO - Journal of Hard Tissue Biology

JF - Journal of Hard Tissue Biology

SN - 1341-7649

IS - 3

ER -